Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Daly

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Radiation Research|September 9, 1999
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RASE Cohen-Jonathan, C Toulas, I Ader, et al.
Biology Letters|April 9, 2010
A blooming jellyfish in the northeast Atlantic and MediterraneanP Licandro, D V P Conway, M N Daly Yahia, et al.
Immunogenetics|January 1, 1997
The MHC contains multiple genes potentially relevant to hemochromatosisG K Tay, C Leelayuwat, M J Chorney, et al.
Human Immunology|September 1, 1993
Characterization of 4AOHW cell line panel including new data for the 10IHW panelM A Degli-Esposti, M S Griffiths, L N Daly, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 5, 2014
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?A Levy, P Blanchard, S Temam, et al.
The American Journal of Physiology|July 1, 1990
Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitroM C Michel, E Schlicker, K Fink, et al.
Oral Oncology|June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastomaA Modesto, P Blanchard, Y G Tao, et al.
Bulletin Du Cancer|October 2, 2001
[Assessing the quality of patients' medical records at the Claudius-Regaud Institute]L Molinier, R Aziza, D Baillet, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery diseaseJoseph Murphy, R Scott Wright, Ihor Gussak, et al.
Journal of the American College of Cardiology|July 14, 2001
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-upK P Alexander, L K Newby, A S Hellkamp, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Radiation Research|September 9, 1999
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RASE Cohen-Jonathan, C Toulas, I Ader, et al.
Biology Letters|April 9, 2010
A blooming jellyfish in the northeast Atlantic and MediterraneanP Licandro, D V P Conway, M N Daly Yahia, et al.
Immunogenetics|January 1, 1997
The MHC contains multiple genes potentially relevant to hemochromatosisG K Tay, C Leelayuwat, M J Chorney, et al.
Human Immunology|September 1, 1993
Characterization of 4AOHW cell line panel including new data for the 10IHW panelM A Degli-Esposti, M S Griffiths, L N Daly, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 5, 2014
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?A Levy, P Blanchard, S Temam, et al.
The American Journal of Physiology|July 1, 1990
Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitroM C Michel, E Schlicker, K Fink, et al.
Oral Oncology|June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastomaA Modesto, P Blanchard, Y G Tao, et al.
Bulletin Du Cancer|October 2, 2001
[Assessing the quality of patients' medical records at the Claudius-Regaud Institute]L Molinier, R Aziza, D Baillet, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery diseaseJoseph Murphy, R Scott Wright, Ihor Gussak, et al.
Journal of the American College of Cardiology|July 14, 2001
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-upK P Alexander, L K Newby, A S Hellkamp, et al.
Pageof 14